Overview

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Status:
Not yet recruiting

Trial end date:
2027-11-01

Target enrollment:

Participant gender:

Summary

An adaptive, two-arm, RCT of immunosuppression reduction/modification (usual care) with and without IVIG in kidney and SPK recipients with BKPyV infections.

Phase:

Phase 3

Details

Lead Sponsor:

The University of Queensland

Treatments:

Antibodies
gamma-Globulins
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin